U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C33H50N4O6S.CH4O3S
Molecular Weight 726.944
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of REMIKIREN MESYLATE

SMILES

CS(O)(=O)=O.CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3CCCCC3)[C@@H](O)[C@@H](O)C4CC4

InChI

InChIKey=LYIKIXHUJZIDKE-KTASVBIRSA-N
InChI=1S/C33H50N4O6S.CH4O3S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24;1-5(2,3)4/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40);1H3,(H,2,3,4)/t25-,27+,28+,29+,30-;/m1./s1

HIDE SMILES / InChI

Molecular Formula CH4O3S
Molecular Weight 96.106
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C33H50N4O6S
Molecular Weight 630.838
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Remikiren (Ro 42-5892) is a very potent renin inhibitor in vitro and in vivo. Clinical results show that remikiren is a potent orally active renin inhibitor inducing a long lasting blood pressure decrease. Remikiren development has been discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P00797
Gene ID: 5972.0
Gene Symbol: REN
Target Organism: Homo sapiens (Human)
0.7 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Discovery of remikiren as the first orally active renin inhibitor.
1993 Feb
Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals.
1996 Mar
Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
2005 Feb
Purification and characterization of recombinant human renin for X-ray crystallization studies.
2008 Jun 26
Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors.
2008 May
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.
2009

Sample Use Guides

Patients with essential hypertension: 600 mg orally for 8 days
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:31:12 GMT 2023
Edited
by admin
on Fri Dec 15 15:31:12 GMT 2023
Record UNII
1Y25T426Y9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
REMIKIREN MESYLATE
Common Name English
1H-IMIDAZOLE-4-PROPANAMIDE, N-(1-(CYCLOHEXYLMETHYL)-3-CYCLOPROPYL-2,3-DIHYDROXYPROPYL)-.ALPHA.-((2-(((1,1-DIMETHYLETHYL)SULFONYL)METHYL)-1-OXO-3-PHENYLPROPYL)AMINO)-, (1S-(1R*(R*(R*)),2S*,3R*))-, MONOMETHANESULFONATE (SALT)
Systematic Name English
REMIKIREN MESILATE
Common Name English
Code System Code Type Description
FDA UNII
1Y25T426Y9
Created by admin on Fri Dec 15 15:31:12 GMT 2023 , Edited by admin on Fri Dec 15 15:31:12 GMT 2023
PRIMARY
CAS
141078-87-7
Created by admin on Fri Dec 15 15:31:12 GMT 2023 , Edited by admin on Fri Dec 15 15:31:12 GMT 2023
PRIMARY
PUBCHEM
131634716
Created by admin on Fri Dec 15 15:31:12 GMT 2023 , Edited by admin on Fri Dec 15 15:31:12 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE